Skip to main content
. 2014 Aug 27;289(41):28676–28688. doi: 10.1074/jbc.M114.563593

TABLE 1.

LC-MS/MS parameters for quinoxaline quantitation

Quinoxaline and letter assignment (see Fig. 2) Retention time Precursor ion
Product ion 1a
Product ion 2b
Product ion 3b
m/z DPc m/z CEd CXPe m/z CE CXP m/z CE CXP
min amuf V amu eV V amu eV V amu eV V
2,3-DKG (a) 9.5 265.1 40 185.1 23.0 11.0 221.1 17.0 17.0 161.0 27.0 11.0
Glucosone (b) 9.9 251.1 55 173.1 24.0 16.0 161.1 30.0 13.0 233.2 19.0 16.0
Oxalic acid (c) 10.5 162.9 70 90.1 42.0 15.0 145.1 25.0 10.0 117.1 31.0 7.0
Pentosone (d) 11.2 221.1 50 173.1 22.0 14.0 161.0 27.0 13.0 132.1 45.0 10.0
1-DG (e) 11.9 235.2 55 175.1 28.0 12.0 187.1 27.0 11.0 217.2 18.0 16.0
DHA (f) 12.0 247.1 55 229.0 18.0 20.0 185.3 20.0 15.0 171.1 33.0 10.0
3-DG (g) 13.9 235.2 55 199.1 24.0 17.0 145.0 31.0 9.0 157.1 12.0 30.0
Threosone (h) 14.0 191.2 45 173.1 17.5 14.0 144.1 37.0 11.0 161.2 24.0 12.0
1-DP (i) 16.8 205.1 50 187.1 21.0 14.0 145.1 27.0 12.0 169.2 30.0 11.0
Glyoxylic acid (j) 17.1 147.1 65 129.0 26.5 9.0 119.1 30.0 10.0 102.1 39.0 8.5
3-DP (k) 17.1 205.1 50 187.2 19.5 10.0 158.1 34.0 14.0 174.1 32.5 13.0
Lederer's glucosone 18.4 363.3 65 187.1 27.0 16.0 159.1 29.0 10.0 219.1 24.0 12.0
3-DT (l) 19.2 175.1 55 157.2 24.0 10.0 129.2 35.0 9.0 145.0 25.5 10.0
DHA precursor (m) 19.5 355.3 52 109.2 19.0 8.0 247.2 15.0 16.0 337.2 15.0 12.0
Pyruvic acid (n) 19.5 160.9 60 133.1 28.0 10.0 91.9 40.0 7.0 64.9 54.0 11.0
Pyruvic acid-13C2 19.5 163.1 60 134.0 28.0 10.0 92.1 40.0 7.0 64.9 54.0 11.0
1-DT (o) 19.6 175.1 45 157.1 22.0 7.0 156.1 35.0 15.0 89.1 55.0 5.0
3,4-DDP (p) 20.5 189.1 55 171.2 25.0 15.0 145.1 25.0 11.0 102.1 52.0 16.0
GO (q) 20.9 131.1 32 77.0 40.0 6.0 104.0 30.0 8.0
MGO (r) 22.3 145.0 50 77.0 41.0 5.0 118.1 30.5 7.0 65.0 45.0 5.0

a MRM transition used for quantitation (quantifier).

b MRM transition used for confirmation (qualifier).

c DP, declustering potential.

d CE, collision energy.

e CXP, collision cell exit potential.

f amu, atomic mass units.